Curcumin and vitamin E improve hot flashes, lipid profile, and fasting blood glucose without any detrimental effect on the liver and renal function in postmenopausal women: A triple-blind placebo-controlled clinical trial

Health Care Women Int. 2024;45(11):1184-1206. doi: 10.1080/07399332.2022.2117815. Epub 2022 Sep 2.

Abstract

We conducted this study to evaluate the efficacy of Curcumin and vitamin E on hot flashes, lipid profile, blood glucose, and hepatic & renal biomarkers. Eighty-four postmenopausal women were randomly assigned into three groups to receive one Curcumin 500 milligram, vitamin E 200 IU, or placebo capsules twice/daily/eight weeks. In comparison with placebo, vitamin E significantly decreased the number of hot flashes (P = 0.002), serum triglyceride (P < 0.001), and aspartate aminotransferase (P = 0.007), while it increased high-density lipoprotein cholesterol (P = 0.005). Curcumin decreased significantly fasting blood glucose (P = 0.007), total cholesterol (P = 0.015), and triglyceride (P = 0.007) compared to placebo. We conclude that vitamin E reduced the incidence of hot flashes by nearly one-third of the base amount. It improved serum lipid profile and aspartate aminotransferase. Curcumin ameliorated fasting blood glucose and serum lipid profile.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Antioxidants / pharmacology
  • Aspartate Aminotransferases / blood
  • Blood Glucose* / analysis
  • Blood Glucose* / drug effects
  • Curcumin* / pharmacology
  • Curcumin* / therapeutic use
  • Double-Blind Method
  • Fasting / blood
  • Female
  • Hot Flashes* / drug therapy
  • Humans
  • Kidney / drug effects
  • Lipids / blood
  • Liver / drug effects
  • Middle Aged
  • Postmenopause*
  • Treatment Outcome
  • Triglycerides / blood
  • Vitamin E*

Substances

  • Curcumin
  • Vitamin E
  • Blood Glucose
  • Lipids
  • Aspartate Aminotransferases
  • Antioxidants
  • Triglycerides